Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DiMauro

Showing results (901-910 of 942) with videos related to

Pageof 95
Sort By:
Nature Genetics|January 15, 2013
Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial diseaseCornelia Kornblum, Thomas J Nicholls, Tobias B Haack, et al.
Annals of Neurology|June 14, 2000
Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutationsI Nishino, A Spinazzola, A Papadimitriou, et al.
Journal of Medicinal Chemistry|December 4, 2013
Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitorsZihao Hua, Howard Bregman, John L Buchanan, et al.
Physical Review Letters|March 17, 2011
Nonlinear atomic response to intense ultrashort x raysG Doumy, C Roedig, S-K Son, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure-Based Design of Potent and Selective CK1γ InhibitorsHongbing Huang, Lisa Acquaviva, Virginia Berry, et al.
Journal of Medicinal Chemistry|July 22, 2016
Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 InhibitorsErin F DiMauro, Stephen Altmann, Loren M Berry, et al.
The Journal of Physical Chemistry Letters|December 23, 2022
Controlling Fragmentation of the Acetylene Cation in the Vacuum Ultraviolet via Transient Molecular AlignmentL Varvarezos, J Delgado-Guerrero, M Di Fraia, et al.
Nature|March 31, 2022
A highly magnified star at redshift 6.2Brian Welch, Dan Coe, Jose M Diego, et al.
Journal of Medicinal Chemistry|February 12, 2026
Discovery and In Vivo Evaluation of Aryl Ether YAP1/TEAD Inhibitors for the Treatment of Hippo-Driven MalignanciesBrandon A Vara, Jongwon Lim, Casey J Moure, et al.
Journal of Medicinal Chemistry|March 30, 2026
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's DiseaseElsie C Yu, Hua Zhou, Xin Yan, et al.
Pageof 95

Showing results (901-910 of 942) with videos related to

Sort By:
Pageof 95
Nature Genetics|January 15, 2013
Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial diseaseCornelia Kornblum, Thomas J Nicholls, Tobias B Haack, et al.
Annals of Neurology|June 14, 2000
Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutationsI Nishino, A Spinazzola, A Papadimitriou, et al.
Journal of Medicinal Chemistry|December 4, 2013
Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitorsZihao Hua, Howard Bregman, John L Buchanan, et al.
Physical Review Letters|March 17, 2011
Nonlinear atomic response to intense ultrashort x raysG Doumy, C Roedig, S-K Son, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure-Based Design of Potent and Selective CK1γ InhibitorsHongbing Huang, Lisa Acquaviva, Virginia Berry, et al.
Journal of Medicinal Chemistry|July 22, 2016
Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 InhibitorsErin F DiMauro, Stephen Altmann, Loren M Berry, et al.
The Journal of Physical Chemistry Letters|December 23, 2022
Controlling Fragmentation of the Acetylene Cation in the Vacuum Ultraviolet via Transient Molecular AlignmentL Varvarezos, J Delgado-Guerrero, M Di Fraia, et al.
Nature|March 31, 2022
A highly magnified star at redshift 6.2Brian Welch, Dan Coe, Jose M Diego, et al.
Journal of Medicinal Chemistry|February 12, 2026
Discovery and In Vivo Evaluation of Aryl Ether YAP1/TEAD Inhibitors for the Treatment of Hippo-Driven MalignanciesBrandon A Vara, Jongwon Lim, Casey J Moure, et al.
Journal of Medicinal Chemistry|March 30, 2026
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's DiseaseElsie C Yu, Hua Zhou, Xin Yan, et al.
Pageof 95